Abingworth closes 11th life sciences fund on $105m

Many investors in the Abingworth Clinical Co-Development Fund were family offices and funds of funds.

21 January 2016•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.